Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06647511 · ClinicalTrials.gov registry record
Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women
A clinical trial of Gestational Hypertension, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06647511: Recruiting study of Gestational Hypertension, sponsored by Weill Medical College of Cornell University.
NCT06647511 is a study of Gestational Hypertension that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 75 participants, below the 1,354-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06647511, a study of Gestational Hypertension, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are: * Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation? * Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers? * Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure? Participants will: * Complete baseline and follow-up in-person appointments; * Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy; * Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.
Primary Outcome
The diagnostic accuracy of the digital blood pressure cuffs will be compared to the measurements taken during in-person visits.
Conditions Studied
Interventions
- DEVICE Nokia-Withings BPM Connect Blood Pressure Monitor
- DEVICE Smartwatch Devices
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-09-12 |
| Est. Completion | 2026-09 |
What NCT06647511 shows while recruiting
NCT06647511 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,354-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Gestational Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Nokia-Withings BPM Connect Blood Pressure Monitor is the first listed.
NCT06647511 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06647511 about?
NCT06647511 is a clinical study titled "Digital Solutions to Reduce Maternal Morbidity and Mortality in Pregnant Refugee Women". The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are: * Can a digital monitoring system that checks for high blood pressure in th...
What is the current status of trial NCT06647511?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-09-12. Estimated completion is 2026-09.
What conditions does trial NCT06647511 study?
This clinical trial studies the following conditions: Gestational Hypertension.
What interventions are being tested in trial NCT06647511?
The interventions under investigation include: Nokia-Withings BPM Connect Blood Pressure Monitor (DEVICE), Smartwatch Devices (DEVICE).
Who is sponsoring clinical trial NCT06647511?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06647511 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06647511's enrollment target sits among peer trials
75 17th of 18 higher than 2 of 18 other Gestational Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
-
Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI